GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

NCT02714374 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class

Stopped Insufficient funding

Conditions

Interventions

Sponsor

Andrew Lowy

Collaborators